Skip to main content
. 2019 Aug 12;42(4):1413–1421. doi: 10.3892/or.2019.7275

Figure 6.

Figure 6.

Immune activity by BMP7 and BMP6 expression in the ER+ tumors. (A) Infiltrating immune cell comparison between the BMP7 high and low ER+ tumors. (B) Infiltrating immune cell comparison between the BMP6 high and low ER+ tumors. (C) Cytolytic activity, PD1 and PD-L1 expression between the BMP7 high and low ER+ tumors. (D) Cytolytic activity, PD1 and PD-L1 expression between the BMP6 high and low ER+ tumors. BMP, bone morphogenetic protein; ER+, ER-positive; PD1, programmed cell death protein 1; PD-L1, programmed death-ligand 1.